CLYR Health Review

What CLYR Health charges

• Semaglutide: $169/mo — per month, cancel anytime; an eight-week-cycle rate of $130 a month is advertised separately
• Tirzepatide: $249/mo — per month, cancel anytime; the hero on the same page quotes $199 a month, which is the eight-week-cycle rate
• NAD+: $159 — one vial, "try it first · no auto-renew"; three vials are $299 and six are $499
• Sermorelin: $159 — one vial, "try it first · no auto-renew"; three vials are $299 and six are $499
• Glutathione: $249 — one-time, for a ninety-day supply
• PT-141: $119 — the one-month tier; a three-month supply is $199 billed once
• GHK-Cu: $149 — from, billed once, for one bottle; a $249.99 figure on the same page belongs to a competitor column

The unit is printed beside the price

Semaglutide is priced against a stated weekly unit count and a named vial; tirzepatide against a weekly unit ceiling and a stated concentration. NAD+ and sermorelin each name the vial volume and the strength.

That is unusual and it is what makes the figures comparable. A price with no unit attached cannot be set beside anything.

The whole ladder is visible before any intake, so a reader can see the one-vial, three-vial and six-vial rates without handing over a name.

A competitor's column inside its own price table

On the GHK-Cu cream page, a figure sits beside CLYR's own under the label "Leading Rx 3% cream One 60-day bottle · 2 months."

That is somebody else's price presented in the same table as the seller's. Only CLYR's own figure is filed here.

It is not hidden — the label names the comparison — but a reader skimming the table will see two numbers and only one of them is buyable from this seller.

The tirzepatide hero and the tirzepatide ladder disagree

The hero on the tirzepatide page quotes a monthly refill rate. The ladder further down the same page quotes a higher monthly figure for the stated weekly dose.

The lower one is an eight-week-cycle rate rather than a standing monthly charge. The higher one is the standing monthly figure, and that is what is filed here.

The same pattern appears on the semaglutide page, where a cycle rate is advertised separately from the monthly plan. Both sides are on the seller's own pages and neither is reconciled there.

Named pharmacy, unnamed states, and one badge that does not go where it should

It names its pharmacy under pharmacy partners in its terms and names its medical group, so the dispensing chain is not a black box. Its own words: "A state-licensed 503A pharmacy prepares or dispenses the prescription and ships the full pack in plain packaging."

It also states that "Compounded medications are not FDA-approved but are prepared by licensed pharmacies in compliance with applicable regulations." That is quoted, not endorsed.

Its LegitScript badge links to its own explainer article rather than to a listing, so the badge is recorded as a claim. On states it says only that the service is available in certain ones, without naming any.

How we verified this

• Recorded each figure with the unit the seller prints beside it, and checked its multi-vial totals against the savings it claims.
• Identified the competitor column on the cream page from its own label and filed only this seller's figure.
• Read the tirzepatide hero and the ladder below it as one page, established that the hero quotes an eight-week-cycle rate, and filed the standing monthly figure.
• Requested a deliberately meaningless address on this host in the same session and confirmed it returns a not-found response.
• Screened the brand, its named pharmacy and its medical group against the live federal warning-letter table, pulling all 3,677 records in pages and filtering locally because the table's own search parameter is ignored, with a positive and a nonsense control in the same run. No letters for any of them.